Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-16

FDA Approved: AVACLYR — Supplemental Application (Fera Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for AVACLYR (acyclovir) from Fera Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AVACLYR (ACYCLOVIR)

Snippet

SUPPL AP for AVACLYR (ACYCLOVIR)